Biopharma News

Scientists have discovered that TR4 plays an integral role in Cushing's disease

Marijuana use has been associated with lower fasting insulin levels

Improved understanding of the formulation of biofilm could pave the way for new treatments

Cobra Biologics and biotechnology firm Vaccibody AS announce new partnership

An NDA has been submitted for a new pneumonia antibiotic being developed in Taiwan

A biopharmaceutical group has unveiled funding for LSD therapies research

Researchers appear to have uncovered a genetic risk factor for pulmonary fibrosis

The drug may target LRRK2 and JNK enzymes in order to reduce Parkinson's symptoms and slow disease progression.

Dr Raymond Woosley will join the board of directors at ARCA biopharma.

An NDA has been submitted for a new treatment targeting hypertension

Research has revealed 64 per cent of children have been readmitted to hospital after stem cell transplants.

Researchers have reported that benzophenone, which is found in African plants, could prevent tumours from growing.

Researchers are looking at a new treatment for reducing the amount of times a person needs to take insulin for type 1 diabtes.

The company is aiming develop and commercialise innovative new therapies in dermatology.

Researchers have developed a possible vaccine for heroin addiction

Scientists are learning more about how drugs work , which could lead to better, more effective versions.

Research has suggested EPA is associated with skin graft failure

Researchers have made a breakthrough on why some dengue virus patients develop complications

Potential targets have been identified for pharmacological efforts to address obesity

Pre-clinical data on TG1050 was presented at EASL 2013, which took place in Amsterdam

A study has shown chemoresponse assays could be effective for improving ovarian cancer survival rates.

Merck is celebrating after its new melanoma treatment was given Breakout Therapy status by the FDA

Microwave imaging may be a useful way to monitor the effectiveness of breast cancer treatment.

A pain treatment is one step closer to targeting the rare disease erythromelalgia.

A diagnostic kit for rheumatoid arthritis has been given a CE Mark.

A project is in the pipeline to grow a complex 3D tumour microenvironment in vitro.

The debut implantation of a resorbable antibacterial envelope has been revealed.

Research finds effectiveness of smallpox vaccine is down to genes.

A team of scientists are closer to developing an anti-obesity drug

Median Technologies has been awarded a phase II clinical trial on non-small lung cancer

Research has shown how radiation dose can affect size of lung nodules observed on CT images.

A survey has shed light on some physcicians' attitudes to pharmaceutical companies.

A report has suggested FDA review periods for biomarker-based IVD tests are getting longer.

Technology is being developed to predict the effectiveness of radiation therapy.

An antibiotic drug has been found to be beneficial for children with fragile X.

London local authority restricts social housing.

Clinical trial proves link between mental and physical exercise and better cognitive function.

A South Korean firm is working with Chinese CROs to develop its new drug formulation for treatment of depression.

The University of Nottingham is involved in the European Lead Factory drug discovery drive.

Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cel...

Enrollment has been completed for a Phase 2b clinical trial of a lung cancer drug candidate.

The world’s first competitive man-made spider silk fiber, called Biosteel has mechanical properties similar to that of natural spider silk.

The European Medicines Agency recently awarded the Austrian biotech company Activartis an Orphan Drug Designation for its innovative Cancer Immune Therapy AV0113

Combining drug formulations with a device for delivery will make self-administration easier for patients.

A study finds US clinical trials are not revealed in peer-reviewed journals for around 21 months.

Tests based on next-generation sequencing with Roche’s GS Junior System

A collaboration between Almac and DSM Pharmaceutical Products has successfully transferred enzymes for enzyme screening, process development and scale-up manufacture.

A new drug delivery system has been developed by BioChemics that involves creating targeted molecules.

Navidea has announced completion of tests into the impact of mass doses of its NAV4694 biomarker on PET scans of patients with Alzheimer's.

Patients will no longer have to undergo painful autografting for second-degree burns.

avidea has announced completion of tests into the impact of mass doses of its NAV4694 biomarker on PET scans of patients with Alzheimer's.

NGM Biopharmaceuticals has signed a worldwide agreement with Janssen Pharmaceuticals to discover and develop therapeutics for the potential treatment of Type 2 diabetes and other metabolic diseases.

Evotec AG has acquired Cell Culture Service GmbH (CCS), based in Hamburg, Germany, for $1.5 million in cash and an earn-out payment of $1.4 million in cash.

Frost & Sullivan has published its latest research on the global life sciences industry.

Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, has entered into a global sales partnership with Umetrics AB, a Swedish software manufacturer.

Nuron Biotech has expanded its vaccine portfolio with the acquisition of Meningitec from Pfizer

Biopharmaceutical companies in the US are working on a range of treatments for type-1 and type-2 diabetes and related complications.

Sanofi will use Selecta's proprietary synthetic vaccine particle technology to develop highly targeted immunotherapies against life-threatening allergens.

Biogen Idec has opened a new facility focusing on patient care in RTP, North Carolina.

BioCryst's proposed acquisition of Presidio Pharmaceuticals will no longer go ahead.

TOT Biopharm has held an inauguration ceremony for its new factory complex in Suzhou, China.

Sanofi ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM Index) .

Amplion Research's latest report looks at approval trends for biomarker-based IVD tests in the US.

Biopharmaceuticals and biologics in particular are coming into their own, according to the latest GBI Research report.

The Bristol-Myers Squibb Foundation has marked World Diabetes Day and the second anniversary of its Together on Diabetes™ initiative by issuing the initiative's second annual report and awarding two new grants to partners in India.

Sanofi (EURONEXT: SAN and NYSE: SNY) and T1D Exchange, a non-profit organization focused on type 1 diabetes, will collaborate on the TEENs registry study.

BioCat, a distributor of research reagents and cutting-edge technologies in the fields of genomics, proteomics, and cell biology, announces the signing of an exclusive distribution agreement with ALPCO Diagnostics.

Incyte won a $50 million milestone payment from Eli Lilly tied to formal initiation of the rheumatoid arthritis (RA) Phase III program for baricitinib, Incyte’s oral JAK1/JAK2 inhibitor (formerly INCB28050).

Jubilant HollisterStier’s Contract Manufacturing & Services division, a subsidiary of Jubilant Life Sciences, has recently secured more than $100 million in contracts with pharmaceutical companies for the commercial manufacture of multiple sterile...

Catalent Pharma Solutions and Cevec Pharmaceuticals have entered a commercial cell line sales agreement for recombinant human alpha-1 antitrypsin (hAAT).

Boehringer Ingelheim's biopharmaceutical contract manufacturing business and Molecular Partners have entered into a strategic manufacturing collaboration.

The number of voluntarily initiated phase-IV clinical trials has increased in recent years, a study has found.

Sales of Zomig drove income at Impax Laboratories during the third quarter of the year.

Sigma-Aldrich will provide its pre-formulation services to CrystalGenomics in Seoul.

A new report has highlighted key factors for the success of biopharmaceutical innovation.

Novartis is investing more than $500 million in a new facility in Tuas.

Patheon is to acquire Banner Pharmacaps for US$255 million, the company has confirmed.